Suppr超能文献

超越偏见:生物医学研究中利益冲突研究与政策的综合方法

Beyond Bias: Aggregate Approaches to Conflicts of Interest Research and Policy in Biomedical Research.

作者信息

Graham S Scott, Harrison Kimberlyn R, Edward Jade C Shiva, Majdik Zoltan P, Barbour Joshua B, Rousseau Justin F

机构信息

Department of Rhetoric and Writing, Center for Health Communication, The University of Texas at Austin, Austin, TX, USA.

Department of English, The University of Texas at Austin, Austin, TX, USA.

出版信息

World Med Health Policy. 2024 Sep;16(3):489-505. doi: 10.1002/wmh3.608. Epub 2024 Apr 15.

Abstract

Considerable efforts have been devoted to addressing the problem of conflicts of interest (COI) in health research, policy, education, and practice. An overwhelming body of evidence demonstrates that conflicts associate with deleterious outcomes for the biomedical research enterprise. Nevertheless, little has changed for research, specifically, since the Institute of Medicine's landmark was published over a decade ago. In this article, we draw on interdisciplinary research on manufactured controversies in science-policy deliberation to argue that the development of meaningful COI policy has been stymied through argumentative "wedges" designed to delay consensus and policy formation. Argumentative wedges disrupt policy formation by mischaracterizing the evidence base, continuously redefining the terms of the debate and/or recommending overly narrow criteria for who should be allowed to participate in policy deliberation. In this article, we argue researchers and policymakers interested in better addressing the harmful effects of COI can improve their efforts through strategic efforts designed to disrupt the wedges of manufactured controversy. Additionally, we argue that efforts to address COI can be further enhanced through embracing a broader framework for COI inquiry. Specifically, we argue that aggregate approaches to COI can help to disrupt these wedges and provide a strong foundation for future policy.

摘要

为解决健康研究、政策、教育及实践中的利益冲突(COI)问题,人们付出了巨大努力。大量证据表明,利益冲突与生物医学研究事业的有害后果相关。然而,自医学研究所十多年前发表具有里程碑意义的报告以来,研究领域特别是几乎没有什么变化。在本文中,我们借鉴科学政策审议中关于人为制造争议的跨学科研究,认为有意义的利益冲突政策的制定因旨在拖延共识和政策形成的论证“楔子”而受阻。论证楔子通过错误描述证据基础、不断重新定义辩论条件和/或推荐过于狭窄的参与政策审议人员标准来扰乱政策形成。在本文中,我们认为,对更好地应对利益冲突有害影响感兴趣的研究人员和政策制定者可以通过旨在打破人为制造争议楔子的战略努力来改进工作。此外,我们认为,通过采用更广泛的利益冲突调查框架,可以进一步加强应对利益冲突的努力。具体而言,我们认为利益冲突的总体方法有助于打破这些楔子,并为未来政策提供坚实基础。

相似文献

本文引用的文献

10
An overview of the commercial determinants of health.商业健康决定因素概述。
Global Health. 2020 Aug 17;16(1):74. doi: 10.1186/s12992-020-00607-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验